Telogen Effluvium, Diagnosis and Management: A Narrative Review

REVIEW
Ramadan S. Hussein, Salman Bin Dayel

 
International Journal of Biomedicine. 2023;13(1):26-30.
DOI: 10.21103/Article13(1)_RA4
Originally published March 3, 2023

Abstract: 

Telogen effluvium (TE) is a type of alopecia characterized by diffuse, frequently acute hair shedding. Another chronic type with a more gradual onset is also observed. TE is the most prevalent cause of non-scarring diffuse hair shedding. It is a reactive process induced by hormonal changes, metabolic stress, or drugs. An increase in telogen hair loss (HL) does not imply a reason because TE may be confused with other hair disorders. Dermoscopy, a modern diagnostic method, can be used to distinguish a variety of hair diseases. This review discusses the putative causal variables, clinical manifestations, diagnostic techniques, and therapeutic approaches.

Keywords: 
telogen effluvium • trichoscopy • treatment
References: 

1. Harrison S, Sinclair R. Telogen effluvium. Clin Exp Dermatol. 2002 Jul;27(5):389-5. doi: 10.1046/j.1365-2230.2002.01080.x. 
2. Malkud S. Telogen Effluvium: A Review. J Clin Diagn Res. 2015 Sep;9(9):WE01-3. doi: 10.7860/JCDR/2015/15219.6492.
3. Rudnicka L, Olszewska M, Rakowska A, Kowalska-Oledzka E, Slowinska M. Trichoscopy: a new method for diagnosing hair loss. J Drugs Dermatol. 2008 Jul;7(7):651-4.
4. KLIGMAN AM. The human hair cycle. J Invest Dermatol. 1959 Dec;33:307-16. doi: 10.1038/jid.1959.156. 
5. Messenger AG, Berker DA, Sinclair RD. Disorders of hair. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook’s textbook of dermatology, 8th edition. Oxford: Blackwell Publishing; 2010:66.1- 66.100.
6. Brajac I, Vičić M, Periša D, Kaštelan M. Human Hair Follicle: An Update on Biology and Perspectives in Hair Growth Disorders Treatment. Hair Ther Transplant. 2014;4:115. doi:10.4172/2167-0951.1000115
7. Shrivastava SB. Diffuse hair loss in an adult female: approach to diagnosis and management. Indian J Dermatol Venereol Leprol. 2009 Jan-Feb;75(1):20-7; quiz 27-8. doi: 10.4103/0378-6323.45215.
8. Wadhwa SL, Khopkar U, Nischal KC. Hair and scalp disorders. In: Valia RG, Valia AR, editors. IADVL Textbook of dermatology, 3rd edition. Mumbai: Bhalani Publishing House; 2010:864-948.
9. Sperling LC, Sinclair R. Alopecia and hair shaft abnormalities. In: Jean LB, Joseph LJ, Ronald PR, editors. Dermatology (Bolognia), 3rd edition. Elsevier Health Science: London, UK, 2012;(1)):1098–1099.
10. Grover C, Khurana A. Telogen effluvium. Indian J Dermatol Venereol Leprol. 2013 Sep-Oct;79(5):591-603. doi: 10.4103/0378-6323.116731. 
11. Sinclair R. Hair shedding in women: how much is too much? Br J Dermatol. 2015 Sep;173(3):846-8. doi: 10.1111/bjd.13873. 
12. Thai KE, Sinclair RD. Chronic telogen effluvium in a man. J Am Acad Dermatol. 2002 Oct;47(4):605-7. doi: 10.1067/mjd.2002.113675.
13. Gilmore S, Sinclair R. Chronic telogen effluvium is due to a reduction in the variance of anagen duration. Australas J Dermatol. 2010 Aug;51(3):163-7. doi: 10.1111/j.1440-0960.2010.00654.x. 
14. Sinclair R. Chronic telogen effluvium or early androgenetic alopecia? Int J Dermatol. 2004 Nov;43(11):842-3. doi: 10.1111/j.1365-4632.2004.02034.x. 
15. Dawber RPR, Simpson NB, Barth JH. Diffuse alopecia: Endocrine, metabolic and chemical influences on the follicular cycle. In: Dawber RPR, editor. Diseases of the Hair and Scalp. Blackwell Science: Oxford, UK, 1997; pp. 123–150.
16. Kaufman JP. Letter: Telogen effluvium secondary to starvation diet. Arch Dermatol. 1976 May;112(5):731. 
17. Dawber RP, Simpson NB. Hair, and scalp in systemic disease. In: Dawber RP, editor.  Diseases of the Hair and Scalp. Blackwell Science: Oxford, UK; 1997:483–527.
18. Brodin MB. Drug-related alopecia. Dermatol Clin. 1987 Jul;5(3):571-9. 
19. Jain N, Doshi B, Khopkar U. Trichoscopy in alopecias: diagnosis simplified. Int J Trichology. 2013 Oct;5(4):170-8. doi: 10.4103/0974-7753.130385.
20. Sinclair R, Jolley D, Mallari R, Magee J. The reliability of horizontally sectioned scalp biopsies in the diagnosis of chronic diffuse telogen hair loss in women. J Am Acad Dermatol. 2004 Aug;51(2):189-99. doi: 10.1016/s0190-9622(03)00045-8. 
21. Harrison S, Bergfeld W. Diffuse hair loss: its triggers and management. Cleve Clin J Med. 2009 Jun;76(6):361-7. doi: 10.3949/ccjm.76a.08080.
22. Bergfeld WF, Mulinari-Brenner F. Shedding: how to manage a common cause of hair loss. Cleve Clin J Med. 2001 Mar;68(3):256-61. doi: 10.3949/ccjm.68.3.256.
23. Trost LB, Bergfeld WF, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol. 2006 May;54(5):824-44. doi: 10.1016/j.jaad.2005.11.1104.
24. McMichael A. Approach to office visits for hair loss in women. Cutis. 2011 Jan;87(1):8-9. 
25. Buhl AE. Minoxidil's action in hair follicles. J Invest Dermatol. 1991 May;96(5):73S-74S. doi: 10.1111/1523-1747.ep12471911. 
26. Davis MG, Thomas JH, van de Velde S, Boissy Y, Dawson TL Jr, Iveson R, Sutton K. A novel cosmetic approach to treat thinning hair. Br J Dermatol. 2011 Dec;165 Suppl 3:24-30. doi: 10.1111/j.1365-2133.2011.10633.x. 
27. Rathman-Josserand M, Bernard BA, Misra N. Hair Density Recovery: New Insights in Hair Growth Biology—L’Oreal Research: O 10: The Niche of Human Hair Follicle Stem Cells: A Specific Environment. Int J Trichology. 2014;6:113–139.

Download Article
Received January 14, 2023.
Accepted February 23, 2023.
©2023 International Medical Research and Development Corporation.